Juan Kim
Analyst
Citigroup
Equibles does not estimate personal net worth.
About Juan Kim
Juan Kim is recorded as Analyst at Citigroup. Juan Kim has spoken on 2 earnings calls across 2 companies, most recently for Ultragenyx Pharmaceutical Inc. on November 3, 2026. Those appearances were for Ultragenyx Pharmaceutical Inc. (RARE) and Sarepta Therapeutics, Inc. (SRPT). The companies whose calls Juan Kim spoke on are classified in the Healthcare sector.
Juan Kim on recent calls
“For Fayouvi, just wondering, but are physicians and payers interpreting preserved neurodevelopmental functions similarly, or are you seeing any variation in eligibility decisions across centers or specifically across plans?”
“And I also wanted to convey my well wishes to you, Doug, and your family. Maybe on the Cohort 8 data, what do you need for FDA to demonstrate safety? I expect it would be clear for acute liver injury, but would FDA also want to see ALT-ASD elevations in a trial, and what bar would be acceptable on ALT-ASD elevations?”
Affiliation history
-
Citigroup
Analyst
Transcript header (unverified)
Current